Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus.
Konya H, Miuchi M, Satani K, Matsutani S, Yano Y, Tsunoda T, Ikawa T, Matsuo T, Ochi F, Kusunoki Y, Tokuda M, Katsuno T, Hamaguchi T, Miyagawa J, Namba M. Konya H, et al. Among authors: tsunoda t. World J Exp Med. 2015 May 20;5(2):110-9. doi: 10.5493/wjem.v5.i2.110. eCollection 2015 May 20. World J Exp Med. 2015. PMID: 25992325 Free PMC article. Review.
Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients.
Konya H, Yano Y, Matsutani S, Tsunoda T, Ikawa T, Kusunoki Y, Matsuo T, Miuchi M, Katsuno T, Hamaguchi T, Miyagawa J, Namba M. Konya H, et al. Among authors: tsunoda t. Ther Clin Risk Manag. 2014 Jul 11;10:547-58. doi: 10.2147/TCRM.S46076. eCollection 2014. Ther Clin Risk Manag. 2014. PMID: 25050065 Free PMC article. Review.
Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.
Konya H, Miuchi M, Satani K, Matsutani S, Tsunoda T, Yano Y, Katsuno T, Hamaguchi T, Miyagawa J, Namba M. Konya H, et al. Among authors: tsunoda t. World J Diabetes. 2014 Oct 15;5(5):678-88. doi: 10.4239/wjd.v5.i5.678. World J Diabetes. 2014. PMID: 25317245 Free PMC article. Review.
Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study.
Kuroda N, Kusunoki Y, Osugi K, Ohigashi M, Azuma D, Ikeda H, Makino S, Otsuka A, Tamada D, Watanabe N, Washio K, Tsunoda T, Matsuo T, Konishi K, Katsuno T, Koyama H; Hyogo Diabetes Hypoglycemia Cognition Complications (HDHCC) study group. Kuroda N, et al. Among authors: tsunoda t. J Diabetes Investig. 2021 Feb;12(2):244-253. doi: 10.1111/jdi.13336. Epub 2020 Aug 2. J Diabetes Investig. 2021. PMID: 32594655 Free PMC article.
Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2).
Katsuno T, Shiraiwa T, Iwasaki S, Park H, Watanabe N, Kaneko S, Terasaki J, Hanafusa T, Imagawa A, Shimomura I, Ikegami H, Koyama H, Namba M, Miyagawa JI; TRUST2 study group. Katsuno T, et al. Adv Ther. 2021 Mar;38(3):1514-1535. doi: 10.1007/s12325-021-01631-y. Epub 2021 Jan 28. Adv Ther. 2021. PMID: 33507500 Clinical Trial.
Significance of Glycemic Variability in Diabetes Mellitus.
Kusunoki Y, Konishi K, Tsunoda T, Koyama H. Kusunoki Y, et al. Among authors: tsunoda t. Intern Med. 2022 Feb 1;61(3):281-290. doi: 10.2169/internalmedicine.8424-21. Epub 2021 Sep 18. Intern Med. 2022. PMID: 34544956 Free PMC article.
Association between continuous glucose monitoring-derived glycemic control indices and urinary biomarkers of diabetic kidney disease: Hyogo Diabetes Hypoglycemia Cognition Complications study.
Takagi A, Kusunoki Y, Ohigashi M, Osugi K, Inoue C, Inoue M, Tsunoda T, Kadoya M, Konishi K, Katsuno T, Koyama H; Hyogo Diabetes Hypoglycemia Cognition Complications (HDHCC) study group. Takagi A, et al. Among authors: tsunoda t. Acta Diabetol. 2024 Apr;61(4):413-423. doi: 10.1007/s00592-023-02214-9. Epub 2023 Nov 25. Acta Diabetol. 2024. PMID: 38006524 Free PMC article.
1,167 results